Copy number signatures in targeted gene panels associate with patient outcomes in routine clinical data
Targeted gene panels (TGPs) dominate clinical sequencing, yet most copy-number (CN) signature studies rely on genome-wide assays. Whether signatures can be recovered from TGPs and retain clinical relevance remains unclear. We analyzed two real-world TGP cohorts comprising 1,726 patients across 62 tumor types, including 825 with clinical annotations, and made the underlying data publicly…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
